Exhibit 23.1
|
The Directors Biodexa Pharmaceuticals plc 1 Caspian Point Caspian Way Cardiff Wales CF10 4DQ |
DDI: +44 (0)20 7516 2200
Email: dthompson@pkf-l.com
Date: 27 March 2026 |
Consent of Independent Registered Public Accounting Firm
Dear Sir / Madam
We consent to the incorporation by reference of our audit report dated March 27, 2026 on the consolidated financial position of Biodexa Pharmaceuticals plc (the “Group”) and its subsidiaries as of December 31, 2025 (collectively the 2025 20-F) into the prospectus and registration statement included within the Post-Effective Amendment No.1 to Form F-1 regarding the exercise warrants issued in the December 2025 best efforts offering.
Yours faithfully
/s/ PKF Littlejohn LLP
PKF Littlejohn LLP
London, United Kingdom
PKF Littlejohn LLP, Chartered Accountants. A list of members’
names is available at the address below. PKF Littlejohn LLP |
PKF Littlejohn LLP 15 Westferry Circus Canary Wharf, London E14 4HD
T: +44 (0)20 7516 2200 pkf-l.com |